Which has higher earnings & valuation, OPRX or CCLD?

CareCloud has higher revenue and earnings than OptimizeRx. CareCloud is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OptimizeRx $109.43M 1.26 $5.13M $0.23 31.70 CareCloud $120.50M 0.72 $10.80M $0.07 29.29

Is OPRX or CCLD more profitable?

CareCloud has a net margin of 6.21% compared to OptimizeRx's net margin of 4.66%. CareCloud's return on equity of 27.07% beat OptimizeRx's return on equity. Company Net Margins Return on Equity Return on Assets OptimizeRx 4.66% 9.44% 7.11% CareCloud 6.21% 27.07% 14.56%

Which has better valuation and earnings, CCLD or DRIO?

CareCloud has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareCloud $120.50M 0.72 $10.80M $0.07 29.29 DarioHealth $22.36M 3.10 -$41.71M -$6.13 N/A

Is CCLD or DRIO more profitable?

CareCloud has a net margin of 6.21% compared to DarioHealth's net margin of -169.87%. CareCloud's return on equity of 27.07% beat DarioHealth's return on equity. Company Net Margins Return on Equity Return on Assets CareCloud 6.21% 27.07% 14.56% DarioHealth -169.87% -54.81% -33.36%

CareCloud (CCLD) Competitors

$2.05 +0.01 (+0.49%)

Closing price 04:00 PM Eastern

Extended Trading

$2.06 +0.01 (+0.24%)

As of 07:30 PM Eastern

Compare

CCLD vs. AMWL, OPRX, HCAT, DH, and DRIO

Should you buy CareCloud stock or one of its competitors? CareCloud's main competitors and comparable companies include American Well (AMWL), OptimizeRx (OPRX), Health Catalyst (HCAT), Definitive Healthcare (DH), and DarioHealth (DRIO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does CareCloud compare to American Well?

American Well (NYSE:AMWL) and CareCloud (NASDAQ:CCLD) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and institutional ownership.

CareCloud has a net margin of 6.21% compared to American Well's net margin of -35.75%. CareCloud's return on equity of 27.07% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Well	-35.75%	-30.12%	-22.30%
CareCloud	6.21%	27.07%	14.56%

CareCloud has lower revenue, but higher earnings than American Well. American Well is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Well	$249.32M	0.86	-$95.70M	-$4.77	N/A
CareCloud	$120.50M	0.72	$10.80M	$0.07	29.29

56.1% of American Well shares are owned by institutional investors. Comparatively, 10.2% of CareCloud shares are owned by institutional investors. 12.8% of American Well shares are owned by insiders. Comparatively, 14.8% of CareCloud shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

American Well presently has a consensus target price of $9.50, suggesting a potential downside of 27.04%. CareCloud has a consensus target price of $3.25, suggesting a potential upside of 58.54%. Given CareCloud's stronger consensus rating and higher probable upside, analysts plainly believe CareCloud is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, American Well and American Well both had 1 articles in the media. CareCloud's average media sentiment score of 1.87 beat American Well's score of 0.50 indicating that CareCloud is being referred to more favorably in the news media.

Company	Overall Sentiment
American Well	Positive
CareCloud	Very Positive

American Well has a beta of 1.71, meaning that its share price is 71% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.5, meaning that its share price is 50% more volatile than the broader market.

Summary

CareCloud beats American Well on 9 of the 13 factors compared between the two stocks.

How does CareCloud compare to OptimizeRx?

OptimizeRx (NASDAQ:OPRX) and CareCloud (NASDAQ:CCLD) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, media sentiment, risk, valuation, profitability, analyst recommendations and institutional ownership.

OptimizeRx presently has a consensus price target of $11.43, suggesting a potential upside of 56.77%. CareCloud has a consensus price target of $3.25, suggesting a potential upside of 58.54%. Given CareCloud's higher possible upside, analysts clearly believe CareCloud is more favorable than OptimizeRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

CareCloud has a net margin of 6.21% compared to OptimizeRx's net margin of 4.66%. CareCloud's return on equity of 27.07% beat OptimizeRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptimizeRx	4.66%	9.44%	7.11%
CareCloud	6.21%	27.07%	14.56%

76.5% of OptimizeRx shares are owned by institutional investors. Comparatively, 10.2% of CareCloud shares are owned by institutional investors. 7.5% of OptimizeRx shares are owned by insiders. Comparatively, 14.8% of CareCloud shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

CareCloud has higher revenue and earnings than OptimizeRx. CareCloud is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$109.43M	1.26	$5.13M	$0.23	31.70
CareCloud	$120.50M	0.72	$10.80M	$0.07	29.29

In the previous week, OptimizeRx had 1 more articles in the media than CareCloud. MarketBeat recorded 2 mentions for OptimizeRx and 1 mentions for CareCloud. CareCloud's average media sentiment score of 1.87 beat OptimizeRx's score of 0.93 indicating that CareCloud is being referred to more favorably in the news media.

Company	Overall Sentiment
OptimizeRx	Positive
CareCloud	Very Positive

OptimizeRx has a beta of 1.09, indicating that its share price is 9% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.5, indicating that its share price is 50% more volatile than the broader market.

Summary

CareCloud beats OptimizeRx on 9 of the 16 factors compared between the two stocks.

How does CareCloud compare to Health Catalyst?

CareCloud (NASDAQ:CCLD) and Health Catalyst (NASDAQ:HCAT) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.

CareCloud has a beta of 1.5, suggesting that its share price is 50% more volatile than the broader market. Comparatively, Health Catalyst has a beta of 1.53, suggesting that its share price is 53% more volatile than the broader market.

CareCloud has a net margin of 6.21% compared to Health Catalyst's net margin of -90.61%. CareCloud's return on equity of 27.07% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	6.21%	27.07%	14.56%
Health Catalyst	-90.61%	-1.83%	-0.80%

In the previous week, Health Catalyst had 3 more articles in the media than CareCloud. MarketBeat recorded 4 mentions for Health Catalyst and 1 mentions for CareCloud. CareCloud's average media sentiment score of 1.87 beat Health Catalyst's score of 0.91 indicating that CareCloud is being referred to more favorably in the media.

Company	Overall Sentiment
CareCloud	Very Positive
Health Catalyst	Positive

CareCloud has higher earnings, but lower revenue than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$120.50M	0.72	$10.80M	$0.07	29.29
Health Catalyst	$311.14M	0.41	-$177.97M	-$3.68	N/A

10.2% of CareCloud shares are owned by institutional investors. Comparatively, 85.0% of Health Catalyst shares are owned by institutional investors. 14.8% of CareCloud shares are owned by company insiders. Comparatively, 19.4% of Health Catalyst shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

CareCloud presently has a consensus price target of $3.25, suggesting a potential upside of 58.54%. Health Catalyst has a consensus price target of $2.45, suggesting a potential upside of 44.12%. Given CareCloud's stronger consensus rating and higher possible upside, analysts plainly believe CareCloud is more favorable than Health Catalyst.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Health Catalyst	1 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18

Summary

CareCloud beats Health Catalyst on 9 of the 15 factors compared between the two stocks.

How does CareCloud compare to Definitive Healthcare?

Definitive Healthcare (NASDAQ:DH) and CareCloud (NASDAQ:CCLD) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends.

Definitive Healthcare presently has a consensus price target of $1.47, suggesting a potential upside of 40.14%. CareCloud has a consensus price target of $3.25, suggesting a potential upside of 58.54%. Given CareCloud's stronger consensus rating and higher probable upside, analysts plainly believe CareCloud is more favorable than Definitive Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	3 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.90
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 10.2% of CareCloud shares are owned by institutional investors. 17.1% of Definitive Healthcare shares are owned by insiders. Comparatively, 14.8% of CareCloud shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Definitive Healthcare has a beta of 1.4, indicating that its stock price is 40% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.5, indicating that its stock price is 50% more volatile than the broader market.

CareCloud has lower revenue, but higher earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$241.52M	0.46	-$138.93M	-$1.60	N/A
CareCloud	$120.50M	0.72	$10.80M	$0.07	29.29

In the previous week, Definitive Healthcare had 3 more articles in the media than CareCloud. MarketBeat recorded 4 mentions for Definitive Healthcare and 1 mentions for CareCloud. CareCloud's average media sentiment score of 1.87 beat Definitive Healthcare's score of 0.45 indicating that CareCloud is being referred to more favorably in the news media.

Company	Overall Sentiment
Definitive Healthcare	Neutral
CareCloud	Very Positive

CareCloud has a net margin of 6.21% compared to Definitive Healthcare's net margin of -72.28%. CareCloud's return on equity of 27.07% beat Definitive Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-72.28%	3.55%	1.63%
CareCloud	6.21%	27.07%	14.56%

Summary

CareCloud beats Definitive Healthcare on 11 of the 17 factors compared between the two stocks.

How does CareCloud compare to DarioHealth?

CareCloud (NASDAQ:CCLD) and DarioHealth (NASDAQ:DRIO) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment.

CareCloud has a net margin of 6.21% compared to DarioHealth's net margin of -169.87%. CareCloud's return on equity of 27.07% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	6.21%	27.07%	14.56%
DarioHealth	-169.87%	-54.81%	-33.36%

CareCloud presently has a consensus price target of $3.25, indicating a potential upside of 58.54%. DarioHealth has a consensus price target of $10.00, indicating a potential upside of 41.16%. Given CareCloud's stronger consensus rating and higher probable upside, equities research analysts plainly believe CareCloud is more favorable than DarioHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

CareCloud has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$120.50M	0.72	$10.80M	$0.07	29.29
DarioHealth	$22.36M	3.10	-$41.71M	-$6.13	N/A

10.2% of CareCloud shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 14.8% of CareCloud shares are owned by insiders. Comparatively, 3.5% of DarioHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

CareCloud has a beta of 1.5, indicating that its stock price is 50% more volatile than the broader market. Comparatively, DarioHealth has a beta of 1.12, indicating that its stock price is 12% more volatile than the broader market.

In the previous week, DarioHealth had 2 more articles in the media than CareCloud. MarketBeat recorded 3 mentions for DarioHealth and 1 mentions for CareCloud. CareCloud's average media sentiment score of 1.87 beat DarioHealth's score of 0.50 indicating that CareCloud is being referred to more favorably in the media.

Company	Overall Sentiment
CareCloud	Very Positive
DarioHealth	Neutral

Summary

CareCloud beats DarioHealth on 12 of the 16 factors compared between the two stocks.

Get CareCloud News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCLD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CCLD vs. The Competition

Export

Metric	CareCloud	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$86.69M	$1.69B	$7.12B	$12.83B
Dividend Yield	N/A	4.70%	2.56%	10.57%
P/E Ratio	6.38	20.39	273.26	25.18
Price / Sales	0.72	88.35	638.34	89.67
Price / Cash	2.96	31.51	77.33	51.83
Price / Book	1.46	5.96	10.33	6.20
Net Income	$10.80M	-$18.66M	$3.49B	$358.38M
7 Day Performance	-8.07%	-1.37%	-3.29%	-2.35%
1 Month Performance	-15.98%	3.17%	-0.26%	-2.61%
1 Year Performance	-45.91%	-15.41%	17.32%	8.08%

CareCloud Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCLD CareCloud	3.9638 of 5 stars	$2.05 +0.5%	$3.25 +58.5%	-41.7%	$86.69M	$120.50M	6.38	3,650	Positive News
AMWL American Well	2.1099 of 5 stars	$13.33 +2.6%	$9.50 -28.7%	+95.3%	$220.56M	$249.32M	N/A	1,040
OPRX OptimizeRx	3.7854 of 5 stars	$7.60 -3.4%	$11.43 +50.4%	-59.1%	$143.15M	$98.65M	33.04	100
HCAT Health Catalyst	3.3388 of 5 stars	$1.70 +0.6%	$2.45 +44.1%	-46.9%	$127.94M	$311.14M	N/A	1,200
DH Definitive Healthcare	2.9624 of 5 stars	$1.02 -2.9%	$1.47 +44.3%	-74.1%	$108.89M	$241.52M	N/A	970

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CCLD) was last updated on 9/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CareCloud (CCLD) Competitors

CCLD vs. AMWL, OPRX, HCAT, DH, and DRIO

How does CareCloud compare to American Well?

Summary

How does CareCloud compare to OptimizeRx?

Summary

How does CareCloud compare to Health Catalyst?

Summary

How does CareCloud compare to Definitive Healthcare?

Summary

How does CareCloud compare to DarioHealth?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCLD vs. The Competition

CareCloud Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CareCloud (CCLD) Competitors

CCLD vs. AMWL, OPRX, HCAT, DH, and DRIO

How does CareCloud compare to American Well?

Is AMWL or CCLD more profitable?

Which has stronger earnings & valuation, AMWL or CCLD?

Do insiders & institutionals hold more shares of AMWL or CCLD?

Do analysts recommend AMWL or CCLD?

Does the media favor AMWL or CCLD?

Which has more volatility and risk, AMWL or CCLD?

Summary

How does CareCloud compare to OptimizeRx?

Do analysts rate OPRX or CCLD?

Is OPRX or CCLD more profitable?

Do insiders & institutionals hold more shares of OPRX or CCLD?

Which has higher earnings & valuation, OPRX or CCLD?

Does the media favor OPRX or CCLD?

Which has more risk & volatility, OPRX or CCLD?

Summary

How does CareCloud compare to Health Catalyst?

Which has more risk and volatility, CCLD or HCAT?

Is CCLD or HCAT more profitable?

Does the media refer more to CCLD or HCAT?

Which has higher earnings & valuation, CCLD or HCAT?

Do insiders and institutionals hold more shares of CCLD or HCAT?

Do analysts recommend CCLD or HCAT?

Summary

How does CareCloud compare to Definitive Healthcare?

Do analysts rate DH or CCLD?

Do insiders and institutionals have more ownership in DH or CCLD?

Which has more volatility and risk, DH or CCLD?

Which has higher earnings & valuation, DH or CCLD?

Does the media prefer DH or CCLD?

Is DH or CCLD more profitable?

Summary

How does CareCloud compare to DarioHealth?

Is CCLD or DRIO more profitable?

Do analysts rate CCLD or DRIO?

Which has better valuation and earnings, CCLD or DRIO?

Do insiders and institutionals hold more shares of CCLD or DRIO?

Which has more volatility and risk, CCLD or DRIO?

Does the media refer more to CCLD or DRIO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCLD vs. The Competition

CareCloud Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools